Literature DB >> 1936036

Percutaneous transvenous mitral commissurotomy using the Inoue balloon.

K Inoue1.   

Abstract

The Inoue balloon catheter is unique in function as well as shape, and can be especially adapted for each patient to ensure a high success rate and low morbidity during percutaneous transvenous mitral commissurotomy (PTMC). Before transseptal puncture, right atrial angiography is performed to image the proper point of puncture to avoid not only accidental perforation but also the difficulty of balloon insertion into the mitral orifice. There are two main techniques for inserting the balloon into the mitral orifice. One is a direct method, and the other is loop formation in the left atrium. Balloon selection is basically standardized by patient height; 30 mm for a height of greater than 180 cm, 28 for greater than 160, 26 for greater than 147, 24 for less than 147. However, it should be smaller in valves with severe pathological changes, to prevent mitral regurgitation especially in valves with a mix of strong and weak echoes in the leaflets, combined with strong echo in the commissures shown on 2-dimensional echo-cardiography. For a patient at an advanced age, a smaller balloon should be chosen. A stepwise dilatation technique is effective for preventing the creation of severe mitral regurgitation. Doppler echo-cardiography should be used to decide whether further dilatation is necessary. This will estimate resultant mitral regurgitation, increased mitral valve area and degree of commissure separation. The disappearance of the balloon waist under fluoroscopy is also important in decision making. PTMC is a treatment of choice for mitral stenosis except for fresh mural thrombus and combined severe mitral regurgitation.

Entities:  

Mesh:

Year:  1991        PMID: 1936036     DOI: 10.1093/eurheartj/12.suppl_b.99

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

1.  Mitral balloon valvotomy and left atrial thrombus.

Authors:  T R D Shaw; D B Northridge; N Sutaria
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

2.  Right atrial angiography facilitates transseptal puncture for complex ablation in patients with unusual anatomy.

Authors:  Dominic P S Rogers; Pier D Lambiase; Mehul Dhinoja; Martin D Lowe; Anthony W C Chow
Journal:  J Interv Card Electrophysiol       Date:  2007-01-19       Impact factor: 1.900

3.  Significance of commissural calcification on outcome of mitral balloon valvotomy.

Authors:  N Sutaria; D B Northridge; T R Shaw
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

4.  Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over.

Authors:  N Sutaria; A T Elder; T R Shaw
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

5.  A differentiated morphological parameter-coding system to describe the suitability of mitral valve stenoses intended for percutaneous valvotomy.

Authors:  Nikola Bogunovic; Dieter Horstkotte; Werner Scholtz; Lothar Faber; Lukas Bogunovic; Frank van Buuren
Journal:  Heart Vessels       Date:  2014-06-27       Impact factor: 2.037

6.  Acute changes in left ventricular function after percutaneous transluminal mitral valvuloplasty.

Authors:  R Razzolini; A Ramondo; G Isabella; P Cardaioli; F Campisi; A De Leo; R Chioin
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

7.  A comparison of cylindrical and Inoue balloon techniques for mitral valvotomy in patients in the United Kingdom.

Authors:  T R Shaw; C M Turnbull; P Currie; A D Flapan; S Pringle; B C Lee
Journal:  Br Heart J       Date:  1994-11

8.  Anterior staircase manoeuvre for atrial transseptal puncture.

Authors:  T R Shaw
Journal:  Br Heart J       Date:  1994-03

9.  Clinical and haemodynamic profiles of young, middle aged, and elderly patients with mitral stenosis undergoing mitral balloon valvotomy.

Authors:  T R D Shaw; N Sutaria; B Prendergast
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

10.  N-terminal-pro-brain natriuretic peptide, a surrogate biomarker of combined clinical and hemodynamic outcomes following percutaneous transvenous mitral commissurotomy.

Authors:  K P Ranganayakulu; D Rajasekhar; V Vanajakshamma; C Santosh Kumar; P Vasudeva Chetty
Journal:  J Saudi Heart Assoc       Date:  2015-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.